v3.24.3
Product Sales - Schedule of Concentration of Risk, by Risk Factor (Details) - Gross product revenue - Customer concentration risk
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Besse Medical, a subsidiary of Cencora, Inc.        
Concentration Risk [Line Items]        
Concentration risk, percentage 51.00% 53.00% 51.00% 52.00%
McKesson Corporation        
Concentration Risk [Line Items]        
Concentration risk, percentage 24.00% 24.00% 24.00% 25.00%